Berman Capital Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Berman Capital Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$18K	Sell	50 -1	-2%	-$327	﹤0.01%	1023
2021 Q2	$17K	Hold	51	–	–	﹤0.01%	977
2021 Q1	$17K	Buy	51 +3	+6%	+$993	﹤0.01%	852
2020 Q4	$12K	Hold	48	–	–	﹤0.01%	864
2020 Q3	$13K	Hold	48	–	–	﹤0.01%	727
2020 Q2	$9K	Buy	48 +12	+33%	+$1.95K	﹤0.01%	822
2020 Q1	$4K	Buy	36 +2	+6%	+$313	﹤0.01%	983
2019 Q4	$5K	Hold	34	–	–	﹤0.01%	1001
2019 Q3	$4K	Hold	34	–	–	﹤0.01%	1034
2019 Q2	$4K	Buy	+34	New	+$4.32K	﹤0.01%	1047
2019 Q1	–	Sell	-1	Closed	–	–	1504
2018 Q4	$0	Buy	+1	New	+$133	﹤0.01%	1279

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Berman Capital Advisors's ONC Position: Q3 2021 in Review

Berman Capital Advisors reduced its BeOne Medicines Ltd (ONC) stake by 2% in Q3 2021, selling an estimated $327 and leaving 50 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Berman Capital Advisors first reported a position in ONC in Q4 2018 and has held it in 11 quarters since. 254 funds tracked by Wall St. Rank hold ONC as of Q3 2021.

Berman Capital Advisors held 50 shares of BeOne Medicines Ltd worth $18K as of Q3 2021.
Berman Capital Advisors sold 1 BeOne Medicines Ltd share in Q3 2021, an estimated $327.
BeOne Medicines Ltd made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1023 holding.
Berman Capital Advisors first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 11 quarters since.
254 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.